209 related articles for article (PubMed ID: 31241683)
1. Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial.
Valiengo L; Gordon PC; de Carvalho JB; Rios RM; Koebe S; Serpa MH; van de Bilt M; Lacerda A; Elkis H; Gattaz WF; Brunoni AR
Trends Psychiatry Psychother; 2019 Jun; 41(2):104-111. PubMed ID: 31241683
[TBL] [Abstract][Full Text] [Related]
2. Examining bi-anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex coupled with bilateral extracephalic references as a treatment for negative symptoms in non-acute schizophrenia patients: A randomized, double-blind, sham-controlled trial.
Chang CC; Kao YC; Chao CY; Tzeng NS; Chang HA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109715. PubMed ID: 31362034
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial.
Valiengo LDCL; Goerigk S; Gordon PC; Padberg F; Serpa MH; Koebe S; Santos LAD; Lovera RAM; Carvalho JB; van de Bilt M; Lacerda ALT; Elkis H; Gattaz WF; Brunoni AR
JAMA Psychiatry; 2020 Feb; 77(2):121-129. PubMed ID: 31617873
[TBL] [Abstract][Full Text] [Related]
4. The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase.
Pereira Junior Bde S; Tortella G; Lafer B; Nunes P; Benseñor IM; Lotufo PA; Machado-Vieira R; Brunoni AR
Neural Plast; 2015; 2015():684025. PubMed ID: 25878904
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and auditory biomarker analysis of fronto-temporal transcranial direct current stimulation (tDCS) in targeting cognitive impairment associated with recent-onset schizophrenia: study protocol for a multicenter randomized double-blind sham-controlled trial.
Dondé C; Bastin J; Pouchon A; Costes N; Fakra E; Galvão F; Gay A; Haesebaert F; Lamalle L; Mérida I; Rigon M; Schneider F; Troprès I; Brunelin J; Polosan M
Trials; 2023 Feb; 24(1):141. PubMed ID: 36829240
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial.
Rabanea-Souza T; Cirigola SMC; Noto C; Gomes JS; Azevedo CC; Gadelha A; Cordeiro Q; Dias ÁM; Lacerda ALT
Trials; 2019 Apr; 20(1):199. PubMed ID: 30953544
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Add-on Fronto-Temporal Transcranial Direct Current Stimulation (tDCS) on Auditory Verbal Hallucinations, Other Psychopathological Symptoms, and Insight in Schizophrenia: A Randomized, Double-Blind, Sham-Controlled Trial.
Chang CC; Tzeng NS; Chao CY; Yeh CB; Chang HA
Int J Neuropsychopharmacol; 2018 Nov; 21(11):979-987. PubMed ID: 30107404
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal Transcranial Direct Current Stimulation for Treatment of Schizophrenia With Predominant Negative Symptoms: A Double-Blind, Sham-Controlled Proof-of-Concept Study.
Palm U; Keeser D; Hasan A; Kupka MJ; Blautzik J; Sarubin N; Kaymakanova F; Unger I; Falkai P; Meindl T; Ertl-Wagner B; Padberg F
Schizophr Bull; 2016 Sep; 42(5):1253-61. PubMed ID: 27098066
[TBL] [Abstract][Full Text] [Related]
9. Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial.
Lisoni J; Baldacci G; Nibbio G; Zucchetti A; Butti Lemmi Gigli E; Savorelli A; Facchi M; Miotto P; Deste G; Barlati S; Vita A
J Psychiatr Res; 2022 Nov; 155():430-442. PubMed ID: 36182772
[TBL] [Abstract][Full Text] [Related]
10. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
[TBL] [Abstract][Full Text] [Related]
11. Analgesic effect of cathodal transcranial current stimulation over right dorsolateral prefrontal cortex in subjects with muscular temporomandibular disorders: study protocol for a randomized controlled trial.
Brandão Filho RA; Baptista AF; Brandão Rde A; Meneses FM; Okeson J; de Sena EP
Trials; 2015 Sep; 16():415. PubMed ID: 26381733
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of a single dose of 2 mA of anodal transcranial direct current stimulation over the left dorsolateral prefrontal cortex on executive functions in patients with schizophrenia-A randomized controlled trial.
Schilling TM; Bossert M; König M; Wirtz G; Weisbrod M; Aschenbrenner S
PLoS One; 2021; 16(7):e0254695. PubMed ID: 34270620
[TBL] [Abstract][Full Text] [Related]
13. Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.
Brunelin J; Mondino M; Haesebaert J; Attal J; Benoit M; Chupin M; Dollfus S; El-Hage W; Galvao F; Jardri R; Llorca PM; Magaud L; Plaze M; Schott-Pethelaz AM; Suaud-Chagny MF; Szekely D; Fakra E; Poulet E
Trials; 2021 Dec; 22(1):964. PubMed ID: 34963486
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cortical responses by transcranial direct current stimulation of dorsolateral prefrontal cortex: A resting-state EEG and TMS-EEG study.
Gordon PC; Zrenner C; Desideri D; Belardinelli P; Zrenner B; Brunoni AR; Ziemann U
Brain Stimul; 2018; 11(5):1024-1032. PubMed ID: 29921529
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial.
Gowda SM; Narayanaswamy JC; Hazari N; Bose A; Chhabra H; Balachander S; Bhaskarapillai B; Shivakumar V; Venkatasubramanian G; Reddy YCJ
Brain Stimul; 2019; 12(4):922-929. PubMed ID: 30808612
[TBL] [Abstract][Full Text] [Related]
16. Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study.
Jeon DW; Jung DU; Kim SJ; Shim JC; Moon JJ; Seo YS; Jung SS; Seo BJ; Kim JE; Oh M; Kim YN
Schizophr Res; 2018 Jul; 197():378-385. PubMed ID: 30955702
[TBL] [Abstract][Full Text] [Related]
17. Preliminary findings of four-week, task-based anodal prefrontal cortex transcranial direct current stimulation transferring to other cognitive improvements in schizophrenia.
Weickert TW; Salimuddin H; Lenroot RK; Bruggemann J; Loo C; Vercammen A; Kindler J; Weickert CS
Psychiatry Res; 2019 Oct; 280():112487. PubMed ID: 31376788
[TBL] [Abstract][Full Text] [Related]
18. Effect of transcranial direct current stimulation (tDCS) over the prefrontal cortex combined with cognitive training for treating schizophrenia: a sham-controlled randomized clinical trial.
Shiozawa P; Gomes JS; Ducos DV; Akiba HT; Dias ÁM; Trevizol AP; Uchida RR; Orlov N; Cordeiro Q
Trends Psychiatry Psychother; 2016; 38(3):175-177. PubMed ID: 27737311
[TBL] [Abstract][Full Text] [Related]
19. The effect of transcranial direct current stimulation on psychotic symptoms of schizophrenia is associated with oxy-hemoglobin concentrations in the brain as measured by near-infrared spectroscopy: A pilot study.
Narita Z; Noda T; Setoyama S; Sueyoshi K; Inagawa T; Sumiyoshi T
J Psychiatr Res; 2018 Aug; 103():5-9. PubMed ID: 29754106
[TBL] [Abstract][Full Text] [Related]
20. Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial.
Bulubas L; Goerigk S; Gomes JS; Brem AK; Carvalho JB; Pinto BS; Elkis H; Gattaz WF; Padberg F; Brunoni AR; Valiengo L
Schizophr Res; 2021 Sep; 235():44-51. PubMed ID: 34304146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
